Annual Accounts Payable
$3.79 M
+$791.00 K+26.35%
December 1, 2023
Summary
- As of February 7, 2025, RCEL annual accounts payable is $3.79 million, with the most recent change of +$791.00 thousand (+26.35%) on December 1, 2023.
- During the last 3 years, RCEL annual accounts payable has risen by +$673.00 thousand (+21.57%).
- RCEL annual accounts payable is now -12.46% below its all-time high of $4.33 million, reached on June 30, 2020.
Performance
RCEL Accounts Payable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Accounts Payable
$4.19 M
+$32.00 K+0.77%
September 1, 2024
Summary
- As of February 7, 2025, RCEL quarterly accounts payable is $4.19 million, with the most recent change of +$32.00 thousand (+0.77%) on September 1, 2024.
- Over the past year, RCEL quarterly accounts payable has increased by +$394.00 thousand (+10.39%).
- RCEL quarterly accounts payable is now -6.48% below its all-time high of $4.48 million, reached on March 1, 2024.
Performance
RCEL Quarterly Accounts Payable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Accounts Payable Formula
Accounts Payable = Beginning Accounts Payable + Purchases on Credit − Payments to Suppliers
RCEL Accounts Payable Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +26.4% | +10.4% |
| 3 y3 years | +21.6% | +71.7% |
| 5 y5 years | +98.0% | +15.1% |
RCEL Accounts Payable Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +40.1% | -6.5% | +74.7% |
| 5 y | 5-year | -12.5% | +98.0% | -6.5% | +74.7% |
| alltime | all time | -12.5% | >+9999.0% | -6.5% | >+9999.0% |
AVITA Medical Accounts Payable History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $4.19 M(+0.8%) |
| Jun 2024 | - | $4.16 M(-7.2%) |
| Mar 2024 | - | $4.48 M(+18.0%) |
| Dec 2023 | $3.79 M(+26.3%) | $3.79 M(+25.6%) |
| Sep 2023 | - | $3.02 M(-21.3%) |
| Jun 2023 | - | $3.84 M(+2.3%) |
| Mar 2023 | - | $3.75 M(+25.0%) |
| Dec 2022 | $3.00 M(+10.9%) | $3.00 M(-16.6%) |
| Sep 2022 | - | $3.60 M(+44.2%) |
| Jun 2022 | - | $2.50 M(+4.1%) |
| Mar 2022 | - | $2.40 M(-1.7%) |
| Dec 2021 | $2.71 M(-13.2%) | - |
| Sep 2021 | - | $2.44 M(-21.8%) |
| Jun 2021 | $3.12 M(-28.0%) | $3.12 M(-14.2%) |
| Mar 2021 | - | $3.64 M(+30.3%) |
| Dec 2020 | - | $2.79 M(-21.8%) |
| Sep 2020 | - | $3.57 M(-17.6%) |
| Jun 2020 | $4.33 M(+126.1%) | $4.33 M(+66.6%) |
| Dec 2019 | - | $2.60 M(+35.8%) |
| Jun 2019 | $1.92 M(+859.4%) | $1.92 M(-39.3%) |
| Dec 2018 | - | $3.16 M(+1481.4%) |
| Jun 2018 | $199.70 K(-73.8%) | $199.70 K(-85.3%) |
| Dec 2017 | - | $1.36 M(+78.4%) |
| Jun 2017 | $760.80 K(-33.9%) | $760.80 K(+24.1%) |
| Dec 2016 | - | $613.00 K(-46.8%) |
| Jun 2016 | $1.15 M(+43.3%) | $1.15 M(+0.3%) |
| Dec 2015 | - | $1.15 M(+42.9%) |
| Jun 2015 | $803.50 K(+93.6%) | $803.50 K(-24.0%) |
| Dec 2014 | - | $1.06 M(+154.8%) |
| Jun 2014 | $415.10 K(-53.2%) | $415.10 K(-65.8%) |
| Dec 2013 | - | $1.21 M(+37.0%) |
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2013 | $886.80 K(-13.9%) | $886.80 K(-43.1%) |
| Dec 2012 | - | $1.56 M(+51.3%) |
| Jun 2012 | $1.03 M(+42.6%) | $1.03 M(-25.2%) |
| Dec 2011 | - | $1.38 M(+90.7%) |
| Jun 2011 | $722.20 K(+132.0%) | $722.20 K(-45.3%) |
| Dec 2010 | - | $1.32 M(+323.9%) |
| Jun 2010 | $311.30 K(+22.2%) | $311.30 K(-59.4%) |
| Dec 2009 | - | $766.20 K(+200.7%) |
| Jun 2009 | $254.80 K(-63.8%) | $254.80 K(-79.1%) |
| Dec 2008 | - | $1.22 M(+73.2%) |
| Jun 2008 | $704.50 K(+85.0%) | $704.50 K(-37.3%) |
| Dec 2007 | - | $1.12 M(+194.9%) |
| Jun 2007 | $380.90 K(-70.1%) | $380.90 K(-66.4%) |
| Dec 2006 | - | $1.13 M(-10.9%) |
| Jun 2006 | $1.27 M(+320.2%) | $1.27 M(+20.9%) |
| Dec 2005 | - | $1.05 M(+53.4%) |
| Dec 2004 | - | $686.40 K(+126.6%) |
| Jun 2004 | $302.90 K(+293.4%) | $302.90 K(-46.8%) |
| Dec 2003 | - | $569.60 K(+240.9%) |
| Jun 2003 | - | $167.10 K(+117.0%) |
| Dec 2002 | $77.00 K(+438.5%) | $77.00 K(+32.8%) |
| Jun 2002 | - | $58.00 K(+305.6%) |
| Dec 2001 | $14.30 K(-60.8%) | - |
| Dec 2001 | - | $14.30 K(+31.2%) |
| Jun 2001 | - | $10.90 K(-70.1%) |
| Dec 2000 | $36.50 K(+676.6%) | - |
| Dec 2000 | - | $36.50 K(-12.7%) |
| Jun 2000 | - | $41.80 K(+789.4%) |
| Dec 1999 | $4700.00(-58.8%) | - |
| Dec 1999 | - | $4700.00(-58.8%) |
| Dec 1998 | $11.40 K | - |
| Dec 1998 | - | $11.40 K |
FAQ
- What is AVITA Medical annual accounts payable?
- What is the all time high annual accounts payable for AVITA Medical?
- What is AVITA Medical annual accounts payable year-on-year change?
- What is AVITA Medical quarterly accounts payable?
- What is the all time high quarterly accounts payable for AVITA Medical?
- What is AVITA Medical quarterly accounts payable year-on-year change?
What is AVITA Medical annual accounts payable?
The current annual accounts payable of RCEL is $3.79 M
What is the all time high annual accounts payable for AVITA Medical?
AVITA Medical all-time high annual accounts payable is $4.33 M
What is AVITA Medical annual accounts payable year-on-year change?
Over the past year, RCEL annual accounts payable has changed by +$791.00 K (+26.35%)
What is AVITA Medical quarterly accounts payable?
The current quarterly accounts payable of RCEL is $4.19 M
What is the all time high quarterly accounts payable for AVITA Medical?
AVITA Medical all-time high quarterly accounts payable is $4.48 M
What is AVITA Medical quarterly accounts payable year-on-year change?
Over the past year, RCEL quarterly accounts payable has changed by +$394.00 K (+10.39%)